The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Effects of PS1 Deficiency on Membrane Protein Trafficking in Neurons
Open accessAbstract
We have examined the trafficking and metabolism of the beta-amyloid precursor protein (APP), an APP homolog (APLP1), and TrkB in neurons that lack PS1. We report that PS1-deficient neurons fail to secrete Abeta, and that the rate of appearance of soluble APP derivatives in the conditioned medium is increased. Remarkably, carboxyl-terminal fragments (CTFs) derived from APP and APLP1 accumulate in PS1-deficient neurons. Hence, PS1 plays a role in promoting intramembrane cleavage and/or degradation of membrane-bound CTFs. Moreover, the maturation of TrkB and BDNF-inducible TrkB autophosphorylation is severely compromised in neurons lacking PS1. We conclude that PS1 plays an essential role in modulating trafficking and metabolism of a selected set of membrane and secretory proteins in neurons.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Tail biopsy samples were used to isolate DNA to confirm the genotype of the strain using previously established primers by PCR93–95.”
From Serum amyloid P secreted by bone marrow adipocytes drives skeletal amyloidosis (2025) · cites this paper as [95]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Characteristics of a human cell line transformed by DNA from human adenovirus type 5
Graham, F. L., Russell, W. C., Smiley, J., & Nairn, R. (1977) · Journal of General Virology · doi:10.1099/0022-1317-36-1-59 · Cited by 4,793
Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
Brewer, G. J., Torricelli, J. R., Evege, E. K., & Price, P. J. (1993) · Journal of Neuroscience Research · doi:10.1002/jnr.490350513 · Cited by 2,325
Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein
De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Annaert, W., Von Figura, K., & Van Leuven, F. (1998) · Nature · doi:10.1038/34910 · Cited by 1,818
Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1
Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C.-M., Pérez‐Tur, J., Hutton, M., Buée, L., Harigaya, Y., Yager, D., et al. (1996) · Nature · doi:10.1038/383710a0 · Cited by 1,486
Borchelt, D. R., Thinakaran, G., Eckman, C. B., Lee, M. K., Davenport, F., Ratovitsky, T., Prada, C.-M., Kim, G., Seekins, S., Yager, D., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80230-5 · Cited by 1,478
Self-citationSuzuki, N., Cheung, T. T., Cai, X.-D., Odaka, A., Otvos, L., Eckman, C., Golde, T. E., & Younkin, S. G. (1994) · Science · doi:10.1126/science.8191290 · Cited by 1,471
Amyloid, the presenilins and Alzheimer’s disease
Hardy, J. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)01030-2 · Cited by 1,370
Citron, M., Westaway, D., Xia, W., Carlson, G., Diehl, T., Levesque, G., Johnson-wood, K., Lee, M., Seubert, P., Davis, A., et al. (1997) · Nature Medicine · doi:10.1038/nm0197-67 · Cited by 1,271
Endoproteolysis of Presenilin 1 and Accumulation of Processed Derivatives In Vivo
Thinakaran, G., Borchelt, D., Lee, M. K., Slunt, H. H., Spitzer, L., Kim, G. J., Ratovitski, T., Davenport, F., Nordstedt, C., Seeger, M., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80291-3 · Cited by 1,025
Self-citation
Research works printed but not linked: 2
- Kim, 1990, Detection and quantitation of amyloid B-peptide with 2 monoclonal antibodies, Neurosci. Res. Commun, 7, 113
- Selkoe, D.J. (1997). Cellular and molecular biology of the beta-amyloid precursor protein and Alzheimer’s disease. In The Molecular and Genetic Basis of Neurological Disease, Second edition, R.N. Rosenberg, S.B. Prusiner, S. DiMauro, and R.L. Barchi, eds. (Boston: Butterworth-Heinemann), pp. 601–612.
Cited by
Sorted by citations
Items 101–200 of 354
Alzheimer’s disease due to loss of function: A new synthesis of the available data
Kepp, K. P. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.06.004 · Cited by 123
Implications of Glycosylation in Alzheimer’s Disease
Haukedal, H., & Freude, K. K. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.625348 · Cited by 114
“…have also been observed to affect the glycosylation and sialylation of the neural cell adhesion molecule (NCAM), essential for brain function (Farquhar et al., 2003), and have an impact on the receptor Tyrosine-related kinase B, known to play a role in neural differentiation (Naruse et al., 1998).”
BackgroundEndosomal transport of neurotrophins: Roles in signaling and neurodegenerative diseases
Bronfman, F. C., Escudero, C. A., Weis, J., & Krüttgen, A. (2007) · Developmental Neurobiology · doi:10.1002/dneu.20513 · Cited by 121
“Interesting studies (Naruse et al., 1998; Hamano et al., 2005) demonstrated abnormal Trk signaling and trafficking in cells overexpressing or lacking PS1.”
BackgroundBerezovska, O., Jack, C. E., McLean, P. J., Aster, J. C., Hicks, C. D., Xia, W., Wolfe, M. S., Kimberly, W. T., Weinmaster, G., Selkoe, D. J., et al. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750583.x · Cited by 118
“Similar arguments about PS1 effects on protein trafficking have been raised in other systems (Naruse et al., 1998; Guo et al., 1999).”
BackgroundInfluentialEpigenetics: A novel therapeutic approach for the treatment of Alzheimer's disease
Adwan, L. I., & Zawia, N. H. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.03.010 · Cited by 118
“In addition, neurons lacking the PS1 gene fail to produce Aβ peptides (De Strooper et al., 1998; Naruse et al., 1998).”
Structure and Function of the γ-Secretase Complex
Wolfe, M. S. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00401 · Cited by 124
Pigino, G. F., Pelsman, A., Mori, H., & Busciglio, J. A. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-03-00834.2001 · Cited by 109
“Deficiency of PS1 inhibits the processing and transport of APP and the maturation of the TrkB receptor (De Strooper et al., 1998; Naruse et al., 1998); PS1 activity also is required for the cleavage of Notch1 at the plasma membrane and the release of the Notch1 intracellular domain (NICD; De…”
BackgroundPresenilin-1 uses phospholipase D1 as a negative regulator of β-amyloid formation
Cai, D., Netzer, W. J., Zhong, M., Lin, Y., Du, G., Frohman, M. A., Foster, D. A., Sisodia, S. S., Xu, H., Gorelick, F. S., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510708103 · Cited by 115
Self-citationProfound and Selective Loss of Catalytic TrkB Immunoreactivity in Alzheimer's Disease
Allen, S. J., Wilcock, G. K., & Dawbarn, D. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1561 · Cited by 111
Nyabi, O., Bentahir, M., Horré, K., Herreman, A., Gottardi-Littell, N. R., Broeckhoven, C. V., Merchiers, P., Spittaels, K., Annaert, W. G., & Strooper, B. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306957200 · Cited by 111
Presenilin 2 Interacts with Sorcin, a Modulator of the Ryanodine Receptor
Pack-Chung, E., Meyers, M. B., Pettingell, W. P., Moir, R. D., Brownawell, A. M., Cheng, I., Tanzi, R. E., & Kim, T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909882199 · Cited by 110
Processing of Notch and amyloid precursor protein by γ-secretase is spatially distinct
Tarassishin, L., Yin, Y. I., Bassit, B., & Li, Y. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408007101 · Cited by 108
Kang, D. E., Yoon, I., Repetto, E., Busse, T., Yermian, N., Ie, L., & Koo, E. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500833200 · Cited by 107
Cell‐free assays for γ‐secretase activity
McLendon, C., Xin, T. A., Ziani‐Cherif, C., Murphy, M. P., Findlay, K. A., Lewis, P. A., Pinnix, I., Sambamurti, K., Wang, R., Fauq, A. H., et al. (2000) · The FASEB Journal · doi:10.1096/fj.00-0286fje · Cited by 106
Wilson, C., Murphy, D. D., Giasson, B. I., Zhang, B., Trojanowski, J. Q., & Lee, V. M. ‐. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200403061 · Cited by 108
“-Synuclein has been shown to be very stable in transfected HEK293 and PC12 cells (Okochi et al., 2000).”
BackgroundNotch and Presenilin: a proteolytic mechanism emerges
Fortini, M. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00261-1 · Cited by 104
Kim, S., Leem, J. Y., Lah, J. J., Slunt, H. H., Levey, A. I., Thinakaran, G., & Sisodia, S. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108245200 · Cited by 103
Self-citationPresenilin structure, function and role in Alzheimer disease
Fraser, P. E., Yang, D.-S., Yu, G., Lévesque, L., Nishimura, M., Arawaka, S., Serpell, L. C., Rogaeva, E. A., & George‐Hyslop, P. S. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00028-4 · Cited by 103
Transgenic mouse models of Alzheimer’s disease
Janus, C., Chishti, M. A., & Westaway, D. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00033-8 · Cited by 101
Beyond γ-secretase activity: The multifunctional nature of presenilins in cell signalling pathways
Duggan, S. P., & McCarthy, J. V. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.10.006 · Cited by 107
“For example, presenilindeficient neurons have been shown to have reduced trafficking of TrkB and EphB receptors to the plasma membrane and diminished neuroprotective qualities of the EphB ligand, efnB [79, 80].”
BackgroundThe Basic Biology of BACE1: A Key Therapeutic Target for Alzheimers Disease
Vassar, R. J., & Cole, S. (2007) · Current Genomics · doi:10.2174/138920207783769512 · Cited by 108
Walsh, D. M., Fadeeva, J. V., LaVoie, M. J., Paliga, K., Eggert, S., Kimberly, W. T., Wasco, W., & Selkoe, D. J. (2003) · Biochemistry · doi:10.1021/bi027375c · Cited by 100
Presenilin-dependent “γ-Secretase” Processing of Deleted in Colorectal Cancer (DCC)
Taniguchi, Y., Kim, S., & Sisodia, S. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300239200 · Cited by 100
Self-citationBACE1 Structure and Function in Health and Alzheimers Disease
Cole, S., & Vassar, R. (2008) · Current Alzheimer Research · doi:10.2174/156720508783954758 · Cited by 98
Presenilin 1 Regulates Pharmacologically Distinct γ-Secretase Activities
Murphy, M. P., Uljon, S., Fraser, P. E., Fauq, A. H., Lookingbill, H. A., Findlay, K. A., Smith, T. E., Lewis, P. A., McLendon, D. C., Wang, R., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002812200 · Cited by 96
Fukumori, A., & Steiner, H. (2016) · The EMBO Journal · doi:10.15252/embj.201694151 · Cited by 94
“Apart from the AD-associated APP (De Strooper et al , 1998; Naruse et al , 1998), c -secretase cleaves many other type I membrane protein substrates (Haapasalo & Kovacs, 2011), foremost the Notch1 receptor (De Strooper et al , 1999; Struhl & Greenwald, 1999), a crucial signaling protein, which has…”
Fast Axonal Transport Misregulation and Alzheimer's Disease
Morfini, G. A., Pigino, G. F., Beffert, U., Busciglio, J. A., & Brady, S. T. (2002) · NeuroMolecular Medicine · doi:10.1385/nmm:2:2:089 · Cited by 95
“Similarly, alterations in transport of selected membrane proteins have been seen in PS1-KO neurons (Naruse et al., 1998).”
Tomita, T., Watabiki, T., Takikawa, R., Morohashi, Y., Takasugi, N., Kopan, R., Strooper, B. D., & Iwatsubo, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011152200 · Cited by 92
Self-citationKim, J., Hamamoto, S., Ravazzola, M., Orci, L., & Schekman, R. W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411091200 · Cited by 90
Wang, R., Tang, P., Wang, P., Boissy, R. E., & Zheng, H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509822102 · Cited by 88
Lysosome and calcium dysregulation in Alzheimer's disease: partners in crime
McBrayer, M. K., & Nixon, R. A. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130201 · Cited by 92
Kopan, R., & Goate, A. (2002) · Neuron · doi:10.1016/s0896-6273(02)00585-8 · Cited by 88
Pharmacological Knock-down of the Presenilin 1 Heterodimer by a Novel γ-Secretase Inhibitor
Beher, D., Wrigley, J. D. J., Nadin, A. J., Evin, G. M., Masters, C. L., Harrison, T., Castro, J. L., & Shearman, M. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103075200 · Cited by 84
Hass, M. R., Sato, C., Kopan, R., & Zhao, G. (2008) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2008.11.014 · Cited by 84
Neuronal protein trafficking associated with Alzheimer disease
Tang, B. L. (2009) · Cell Adhesion & Migration · doi:10.4161/cam.3.1.7254 · Cited by 85
Lead-Induced Endoplasmic Reticulum (ER) Stress Responses in the Nervous System
Qian, Y., & Tiffany‐Castiglioni, E. (2003) · Neurochemical Research · doi:10.1023/a:1021664632393 · Cited by 83
Endogenous Presenilin-1 Targets to Endocytic Rather Than Biosynthetic Compartments
Lah, J. J., & Levey, A. I. (2000) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0861 · Cited by 84
Genetic heterogeneity of Alzheimer's disease: Complexity and advances
Lambert, J., & Amouyel, P. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.05.015 · Cited by 81
Tong, Y., Brandt, G. S., Li, M., Shapovalov, G., Slimko, E. M., Karschin, A., Dougherty, D. A., & Lester, H. A. (2001) · The Journal of General Physiology · doi:10.1085/jgp.117.2.103 · Cited by 78
“7 A; Naruse et al., 1998).”
ResultLessard, C. B., Lussier, M. P., Cayouette, S., Bourque, G., & Boulay, G. (2004) · Cellular Signalling · doi:10.1016/j.cellsig.2004.09.005 · Cited by 77
Wang, L., Rahn, J. J., Lun, X. Q., Sun, B., Kelly, J. J., Weiss, S., Robbins, S. M., Forsyth, P. A., & Senger, D. L. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060289 · Cited by 78
Repetto, E., Yoon, I., Zheng, H., & Kang, D. E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704273200 · Cited by 79
Function and Dysfunction of the Presenilins
Sisodia, S. S., Kim, S. H., & Thinakaran, G. (1999) · The American Journal of Human Genetics · doi:10.1086/302475 · Cited by 76
Self-citationRogers, K., Felsenstein, K. M., Hrdlicka, L., Tu, Z., Albayya, F., Lee, W., Hopp, S., Miller, M.-J., Spaulding, D., Yang, Z., et al. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-61 · Cited by 75
Implication of APP Secretases in Notch Signaling
Hartmann, D., Tournoy, J., Säftig, P., Annaert, W. G., & Strooper, B. D. (2001) · Journal of Molecular Neuroscience · doi:10.1385/jmn:17:2:171 · Cited by 75
“…participation of presenilins in γ-secretase cleavage of APP could subsequently be substantiated in PS1-deficient neurons (De Strooper et al., 1998; Naruse et al., 1998; Song et al., 1999) and in PS1 and PS2 double-deficient cells, in which γ-secretase cleavage is completely gone (Herreman et…”
BackgroundPresenilin 1 Suppresses the Function of C-Jun Homodimers via Interaction with Qm/Jif-1
Imafuku, I., Masaki, T., Waragai, M., Takeuchi, S., Kawabata, M., Hirai, S., Ohno, S., Nee, L. E., Lippa, C. F., Kanazawa, I., et al. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.1.121 · Cited by 76
“The multipass transmembrane structure of PS1, especially of the full-length form, does not contradict this hypothesis, and this kind of activity was actually shown in the case of amyloid protein transport (Naruse et al., 1998).”
Chen, F., Yang, D.-S., Petanceska, S. S., Yang, A. J., Tandon, A., Yu, G., Rozmahel, R. F., Ghiso, J. A., Nishimura, M., Zhang, D. M., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006986200 · Cited by 75
Saura, C. A., Tomita, T., Davenport, F., Harris, C. L., Iwatsubo, T., & Thinakaran, G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.20.13818 · Cited by 75
Self-citationGreenough, M. A., Volitakis, I., Li, Q., Laughton, K. M., Evin, G. M., Ho, M., Dalziel, A. H., Camakaris, J., & Bush, A. I. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.163964 · Cited by 74
Amyloid precursor protein-induced axonopathies are independent of amyloid-β peptides
Stokin, G. B., Almenar-Queralt, A., Gunawardena, S., Rodrigues, E. M., Falzone, T., Kim, J., Lillo, C., Mount, S. L., Roberts, E. A., McGowan, E., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn240 · Cited by 72
A Role for Presenilin 1 in Regulating the Delivery of Amyloid Precursor Protein to the Cell Surface
Leem, J. Y., Saura, C. A., Pietrzik, C. U., Christianson, J. C., Wanamaker, C., King, L. T., Veselits, M., Tomita, T., Gasparini, L., Iwatsubo, T., et al. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0546 · Cited by 73
“Recent genetic and biochemical evidence closely links PS1 and PS2 to a protease activity, termed -secretase, which generates the COOH-terminus of A (De Strooper et al., 1998; Naruse et al., 1998; Wolfe et al., 1999).”
BackgroundSelf-citationHuttunen, H. J., Guénette, S. Y., Peach, C., Greco, C., Xia, W., Kim, D. Y., Barren, C., Tanzi, R. E., & Kovacs, D. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702951200 · Cited by 72
Down-regulation of Endogenous Amyloid Precursor Protein Processing due to Cellular Aging
Kern, A., Roempp, B., Prager, K., Walter, J., & Behl, C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505625200 · Cited by 69
Notch Oncoproteins Depend on γ-Secretase/Presenilin Activity for Processing and Function
Das, I., Craig, C. M., Funahashi, Y., Jung, K., Kim, T.-W., Byers, R. J., Weng, A. P., Kutok, J. L., Aster, J. C., & Kitajewski, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309252200 · Cited by 70
Yu, G., Chen, F., Nishimura, M., Steiner, H., Tandon, A., Kawarai, T., Arawaka, S., Supala, A., Song, Y., Rogaeva, E. A., et al. (2000) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61517-6 · Cited by 71
Protein aggregates and dementia: is there a common toxicity?
Lovestone, S. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.2.152 · Cited by 69
Lowering β-Amyloid Levels Rescues Learning and Memory in a Down Syndrome Mouse Model
Netzer, W. J., Powell, C. M., Nong, Y., Blundell, J. J., Wong, L., Duff, K., Flajolet, M., & Greengard, P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010943 · Cited by 72
“We used 4-month-old Ts65Dn mice and their disomic, colony-mates as controls. We compared APP levels, the β-secretase and α-secretase cleaved APP C-terminal fragments (C99, C89 and C83)”
MethodLoss of Modifier of Cell Adhesion Reveals a Pathway Leading to Axonal Degeneration
Chen, Q., Peto, C. A., Shelton, G. D., Mizisin, A. P., Sawchenko, P. E., & Schubert, D. A. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.3985-08.2009 · Cited by 66
“PS is involved in APP trafficking (Naruse et al., 1998; Cai et al., 2003) and PSmutationsimpairAPPaxonaltransport (Piginoetal.,2003;Lazarovetal.,2007).”
BackgroundSaura, C. A., Tomita, T., Soriano, S., Takahashi, M., Leem, J.-Y., Honda, T., Koo, E. H., Iwatsubo, T., & Thinakaran, G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909624199 · Cited by 65
Self-citationThe role of presenilins in Alzheimer’s disease
Thinakaran, G. (1999) · Journal of Clinical Investigation · doi:10.1172/jci8728 · Cited by 65
“Indeed, it was recently demonstrated that CTF derived from the APP homologue, APLP1, also accumulates in PS1–/– neurons (25).”
BackgroundSelf-citationSelkoe, D. J. (2000) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(99)00054-9 · Cited by 66
Marambaud, P., & Robakis, N. K. R. K. (2004) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2005.00086.x · Cited by 65
“…et al. 2000; Pinnix et al. 2001; Sastre et al. 2001; Weidemann et al. 2002; Yu et al. 2001) APLP-1 & 2 ALID1 & ALID2 (Eggert et al. in press; Naruse et al. 1998; Scheinfeld et al. 2002) Notch NICD (De Strooper et al. 1999; Saxena et al. 2001) ErbB4 B4-ICD (Lee et al. 2002; Ni et al.…”
BackgroundEarly Onset Alzheimer’s Disease and Oxidative Stress
Meraz‐Ríos, M. A., Franco-Bocanegra, D., Toral-Ríos, D., & Campos‐Peña, V. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/375968 · Cited by 65
“In addition to this function, presenilins directly or indirectly regulate the trafficking and metabolism of select membrane proteins in neurons [108].”
BackgroundA novel mechanism for the regulation of amyloid precursor protein metabolism
Chen, Q., Kimura, H., & Schubert, D. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200110151 · Cited by 63
“PS1 controls several aspects of APP metabolism (Sisodia, Amyloid precursor metabolism | Chen et al. 87 2000) and protein breakdown (Niwa et al., 1999; Katayama et al., 2000).”
New insight into protein glycosylation in the development of Alzheimer’s disease
Zhao, J., & Lang, M. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01617-5 · Cited by 63
“The overexpression of either wild-type or mutant PS1 disturbs glycoprotein processing within the Golgi [49], while the deficiency of PS leads to impaired secretion of Aβ proteins [50] (Fig.”
BackgroundFluhrer, R., Friedlein, A., Haass, C., & Walter, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306653200 · Cited by 62
Lambert, J.-C., Mann, D. M. A., Harris, J. M., Chartier-Harlin, M.-C., Cumming, A., Coates, J., Lemmon, H., StClair, D., Iwatsubo, T., & Lendon, C. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.6.353 · Cited by 61
“Considerable research effort has been directed towards understanding the function of PS1 protein. Evidence suggests that it plays a role in cell trafficking”
BackgroundMehler, M. F. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01705-7 · Cited by 61
Presenilins and γ-Secretase in Membrane Proteostasis
Oikawa, N., & Walter, J. (2019) · Cells · doi:10.3390/cells8030209 · Cited by 65
Familial Alzheimer Disease Presenilin-1 Mutations Alter the Active Site Conformation of γ-secretase
Chau, D.-M., Crump, C. J., Villa, J. C., Scheinberg, D. A., & Li, Y. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.300483 · Cited by 60
Localization of presenilin–nicastrin complexes and γ‐secretase activity to the trans‐Golgi network
Siman, R., & Velji, J. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01616.x · Cited by 60
“…the trafficking of c-secretase components or substrates is supported by the finding that PS deficiency interferes with trafficking of the receptor tyrosine kinase TrkB to the plasma membrane, and modifies trafficking of APP and related family members (Naruse et al. 1998; Kaether et al. 2002).”
BackgroundTamboli, I. Y., Prager, K., Thal, D. R., Thelen, K. M., Dewachter, I., Pietrzik, C. U., St. George-Hyslop, P., Sisodia, S. S., De Strooper, B., Heneka, M. T., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2635-08.2008 · Cited by 68
“…affect the subcellular trafficking of individual membrane proteins, including APP, TrkA, telencephalin, tyrosinase, and transferrin, but the underlying molecular mechanisms remain unclear (Naruse et al., 1998; Annaert et al., 2001; Wang et al., 2006; Zhang et al., 2006; Parks and Curtis, 2007).”
BackgroundSelf-citationKhandelwal, A., Chandu, D., Roe, C. M., Kopan, R., & Quatrano, R. S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702038104 · Cited by 61
γ-Secretase: never more enigmatic
Sisodia, S. S., Annaert, W. G., Kim, S., & Strooper, B. D. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01987-1 · Cited by 58
Self-citationAbnormal blood vessel development in mice lacking presenilin-1
Nakajima, M., Yuasa, S., Ueno, M., Takakura, N., Koseki, H., & Shirasawa, T. (2003) · Mechanisms of Development · doi:10.1016/s0925-4773(03)00064-9 · Cited by 57
Genter, M. B., Veldhoven, P. P. V., Jegga, A. G., Sakthivel, B., Kong, S., Stanley, K., Witte, D. P., Ebert, C. L., & Aronow, B. J. (2003) · Physiological Genomics · doi:10.1152/physiolgenomics.00117.2003 · Cited by 57
“, RAB3B (Rab3b); vesicleassociated membrane protein 2 (Vamp2); pantophysin (Pphn); and amyloid- (A4) precursor protein binding (Aplp2) (35, 47, 53, 75)], axonal guidance [e.”
BackgroundPresenilin/γ‐secretase activity regulates protein clearance from the endocytic recycling compartment
Zhang, M., Haapasalo, A., Kim, D. Y., Ingano, L. A. M., Pettingell, W. H., & Kovacs, D. M. (2006) · The FASEB Journal · doi:10.1096/fj.05-5531fje · Cited by 58
Mazzitelli, S., Xu, P., Ferrer, I., Davis, R. J., & Tournier, C. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.4491-11.2011 · Cited by 57
“A similar phenotypic abnormality has been observed in cortical neurons defective in PS1 or expressing lossof-function variants (Naruse et al., 1998).”
BackgroundLleó, A., Berezovska, O., Ramdya, P. P., Fukumoto, H., Raju, S., Shah, T. M., & Hyman, B. T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308480200 · Cited by 56
Subcellular Localization of Presenilins: Association with a Unique Membrane Pool in Cultured Cells
Kim, S., Lah, J. J., Thinakaran, G., Levey, A. I., & Sisodia, S. S. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0280 · Cited by 57
Self-citationPresenilins in the Developing, Adult, and Aging Cerebral Cortex
Wines-Samuelson, M., & Shen, J. (2005) · The Neuroscientist · doi:10.1177/1073858405278922 · Cited by 54
The Value of Transgenic Models for the Study of Neurodegenerative Diseases
Price, D. L., Wong, P. C., Markowska, A. L., Lee, M. K., THINAKAREN, G., Cleveland, D. W., Sisodia, S. S., & Borchelt, D. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06920.x · Cited by 52
Self-citationIwata, H., Tomita, T., Maruyama, K., & Iwatsubo, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007989200 · Cited by 52
Self-citationGeneration of intracellular domain of insulin receptor tyrosine kinase by γ-secretase
Kasuga, K., Kaneko, H., Nishizawa, M., Onodera, O., & Ikeuchi, T. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.06.022 · Cited by 52
Presenilins and the intramembrane proteolysis of proteins: facts and fiction
Strooper, B. D., & Annaert, W. G. (2001) · Nature Cell Biology · doi:10.1038/ncb1001-e221 · Cited by 52
Presenilins as therapeutic targets for the treatment of Alzheimer's disease
Golde, T. E., & Younkin, S. G. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02064-0 · Cited by 49
Closing in on the Amyloid Cascade
Doms, R. W., & Huse, J. T. (2000) · Molecular Neurobiology · doi:10.1385/mn:22:1-3:081 · Cited by 50
“has been obtained on this subject (114,115).”
Synaptic contact number and size in stratum radiatum CA1 of APP/PS1ΔE9 transgenic mice
West, M. J., Bach, G., Søderman, A., & Jensen, J. L. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.01.009 · Cited by 48
Release of a membrane-bound death domain by γ-secretase processing of the p75NTR homolog NRADD
Gowrishankar, K., Zeidler, M. G., & Vincenz, C. (2004) · Journal of Cell Science · doi:10.1242/jcs.01263 · Cited by 49
Genetic studies in Alzheimer's disease
Tang, Y., & Gershon, E. S. (2003) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2003.5.1/yptang · Cited by 52
Lee, K.-W., Im, J., Song, J.-S., Lee, S. H., Lee, H.-J., Ha, H.-Y., Koh, J., Gwag, B. J., Yang, S.-D., Paik, S., et al. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.09.011 · Cited by 48
The multiple paradoxes of presenilins
Checler, F. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00244.x · Cited by 48
“If the role of presenilins as a molecular transporter is privileged, it should be noted that Naruse et al. demonstrated nicely that deletion of presenilin 1 drastically impaired the neuronal intracellular transport of several proteins including bAPP (Naruse et al. 1998).”
BackgroundCulvenor, J. G., Evin, G. M., Cooney, M. A., Wardan, H., Sharples, R. A., Maher, F., Reed, G., Diehlmann, A., Weidemann, A., Beyreuther, K. T., et al. (2000) · Experimental Cell Research · doi:10.1006/excr.1999.4791 · Cited by 45
Wang, H., Luo, W., Zhang, Y., Li, Y., Thinakaran, G., Greengard, P., & Xu, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404345200 · Cited by 47
Self-citationPartial Loss of Presenilin Impairs Age-Dependent Neuronal Survival in the Cerebral Cortex
Watanabe, H., Iqbal, M., Zheng, J., Wines-Samuelson, M., & Shen, J. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.3261-14.2014 · Cited by 48
Loss of presenilin function causes Alzheimer's disease‐like neurodegeneration in the mouse
Chen, Q., Nakajima, A., Choi, S. H., Xiong, X., & Tang, Y. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21601 · Cited by 47
“Interestingly, the results from knockout studies have revealed that these genes have a gradient of importance in neuronal development, with PS1 the most essential (Zheng et al., 1996; Naruse et al., 1998; Herreman et al., 1999); thus, PS1-FAD is the most aggressive and has the earliest onset.”
BackgroundPresenilin 1 is involved in maturation and trafficking of N‐cadherin to the plasma membrane
Uemura, K., Kitagawa, N., Kohno, R., Kuzuya, A., Kageyama, T., Chonabayashi, K., Shibasaki, H., & Shimohama, S. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10753 · Cited by 47
“The majority of the early-onset familial form of Alzheimer’s disease (FAD) has been attributed to mutations in the presenilin 1 (PS1) gene (Rogaev et al., 1995; Sherrington et al., 1995; Haass, 1997).”
BackgroundStructural Biology of Presenilins and Signal Peptide Peptidases
Tomita, T., & Iwatsubo, T. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.r113.463281 · Cited by 46
Self-citationKang, J. G., Pyo, Y. J., Cho, J. W., & Cho, M. H. (2004) · PROTEOMICS · doi:10.1002/pmic.200400898 · Cited by 45
Chan, S. L., Furukawa, K., & Mattson, M. P. (2002) · NeuroMolecular Medicine · doi:10.1385/nmm:2:2:167 · Cited by 45
“This is supported by studies in which deletion of PS1 or its C. elegans homolog affects maturation of proteins such as APP, TrkB, Notch, and nicastrin (Naruse et al., 1998; Kim et al., 2001; Leem et al., 2002).”
Metadata
- Authors
- Naruse, S., Thinakaran, G., Luo, J.-J., Kusiak, J. W., Tomita, T., Iwatsubo, T., Qian, X., Ginty, D. D., Price, D. L., Borchelt, D. R., Wong, P. C., & Sisodia, S. S.
- Affiliations
- University of Chicago (US)
- Johns Hopkins University (US)
- National Institute on Aging (US)
- The University of Tokyo (JP)
- Corresponding author
- Sisodia, Sangram S
- ORCID
- Venue
- Neuron
- Publisher
- Elsevier BV
- Published
- 1998-11
- Volume
- 21
- Issue
- 5
- Pages
- 1213-1221
- ISSN
- 0896-6273 (ISSN-L)
- OpenAlex
- W1994453752
- Cited by
- 355
- References
- 43
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 2 · 2023: 3 · 2022: 1 · 2021: 2 · 2020: 3 · 2019: 2 · 2018: 2 · 2017: 4 · 2016: 5 · 2015: 4 · 2014: 4 · 2013: 12 · 2012: 7
- FWCI
- 22.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Neuron (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (1PO1 AG 14248, P50AG005146, P01AG014248, AG 05146)
- National Institute of Neurological Disorders and Stroke (NS-20471)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- presenilin 1, APP, APLP1, amyloid-beta, carboxyl-terminal fragment, membrane protein trafficking, TrkB, brain-derived neurotrophic factor, autophosphorylation, intramembrane cleavage, protein degradation, Alzheimer's disease, neurons
- MeSH terms
- Alzheimer Disease, Animals, Cells, Cultured, Cerebral Cortex, Fetus, Membrane Proteins, Molecular Sequence Data, Neurons, Amyloid beta-Protein Precursor, Mice, Knockout, Mice, Presenilin-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review